#Quibim, a #Valencia-based #HealthTech company innovating the use of imaging #biomarkers for precision #medicine, announced today the close of its €47.9 million #SeriesA financing in order establish #US presence 🇪🇸 🩻
#Quibim #Valencia #HealthTech #biomarkers #medicine #SeriesA #US